Evidence map›Paper›PMID 36274705›Full record

ArticleFrontiers in microbiology2022

Molecular identification, antifungal susceptibility, and resistance mechanisms of pathogenic yeasts from the China antifungal resistance surveillance trial (CARST-fungi) study.

Qiqi Wang, Xuan Cai, Yun Li, Jianhong Zhao, Zhiyong Liu, Yan Jiang, Ling Meng, Yanming Li, Shiyang Pan, Xiaoman Ai and 5 more

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. EnhancedDrug delivery · 2025
    Article
  2. Article
  3. Isavuconazole activity againstFuture microbiology · 2025
    Article
  4. Article
  5. Article
  6. Future microbiology · 2025
    Review
  7. Article
  8. Article
  9. Yeast species in the respiratory samples of COVID-19 patients; molecular tracking ofFrontiers in cellular and infection microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Qiqi WangDepartment of Dermatology and Venereology, Peking University First Hospital, National Clinical Research Center for Skin and Immune Diseases, Research Center for Medical Mycology, Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Peking University, Beijing, China.
Xuan CaiDepartment of Clinical Laboratory, Renmin Hospital of Wuhan University, Wuhan, China.
Yun LiInstitute of Clinical Pharmacology, Peking University First Hospital, Beijing, China.
Jianhong ZhaoDepartment of Clinical Laboratory Medicine, Second Hospital of Hebei Medical University, Shijiazhuang, China.
Zhiyong LiuDepartment of Laboratory Medicine, Southwest Hospital, Army Medical University, Chongqing, China.
Yan JiangCenter for Clinical Laboratories, Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Ling MengLanzhou University Second Hospital, Lanzhou, China.
Yanming LiDepartment of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha, China.
Shiyang PanFirst Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Xiaoman AiDepartment of Medical Laboratory, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Fang ZhangMedical Research and Laboratory Diagnostic Center, Central Hospital Affiliated to Shandong First Medical University, Jinan, China.
Ruoyu LiDepartment of Dermatology and Venereology, Peking University First Hospital, National Clinical Research Center for Skin and Immune Diseases, Research Center for Medical Mycology, Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Peking University, Beijing, China.
Bo ZhengInstitute of Clinical Pharmacology, Peking University First Hospital, Beijing, China.
Zhe WanDepartment of Dermatology and Venereology, Peking University First Hospital, National Clinical Research Center for Skin and Immune Diseases, Research Center for Medical Mycology, Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Peking University, Beijing, China.
Wei LiuDepartment of Dermatology and Venereology, Peking University First Hospital, National Clinical Research Center for Skin and Immune Diseases, Research Center for Medical Mycology, Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Peking University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To have a comprehensive understanding of epidemiology and antifungal susceptibilities in pathogenic yeasts, the China Antifungal Resistance Surveillance Trial (CARST-fungi) study was conducted. All yeast isolates were identified by ribosomal DNA sequencing. Antifungal susceptibilities were performed using CLSI M27-A4 broth microdilution method. Sequence and expression level of resistant-related genes in resistant/non-wide-type (NWT)

Indexed as

antifungal susceptibilityCandida spp.echinocandinsinvasive fungal diseasesmultidrug resistancepathogenic yeaststriazoles

Identifiers

PMID36274705
PMCPMC9583154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.